CartiHeal
Acquisition in 2021
CartiHeal is a medical device company based in Kfar Sava, Israel, specializing in cartilage and bone regeneration. Founded in 2009, the company has developed the Agili-C implant, a cell-free and off-the-shelf solution designed to address focal articular cartilage and osteochondral defects. This innovative implant promotes the regeneration of hyaline cartilage and the underlying subchondral bone without the need for cells or growth factors, making it a significant advancement in the treatment of cartilage injuries. Given the limited natural healing capacity of hyaline cartilage, CartiHeal's technology offers a promising option for patients suffering from cartilage damage, which can lead to severe pain and disability if untreated. The Agili-C implant can be inserted using arthroscopic or minimally invasive techniques, facilitating faster rehabilitation and enhanced recovery outcomes for patients.
Trice Medical
Series D in 2021
Trice Medical, Inc. is a company that specializes in the development of innovative orthopedic diagnostic devices featuring integrated camera-enabled and needle-based technologies. Founded in 2011 and headquartered in Malvern, Pennsylvania, Trice Medical aims to enhance patient care by providing immediate and accurate diagnostic solutions that can be administered in a physician's office. Their products facilitate minimally invasive procedures that are designed to be painless, cosmetically undetectable, and of surgical grade quality. By optimizing the diagnostic process, Trice Medical seeks to eliminate inaccuracies associated with traditional indirect modalities, thereby reducing costs for the healthcare system while improving the overall patient experience.
Misonix
Acquisition in 2021
Misonix is a leading medical device company specializing in ultrasonic surgical technology. The company designs, manufactures, and markets innovative devices that enhance clinical outcomes in various surgical fields, including neurosurgery, orthopedic surgery, plastic surgery, and wound care. Misonix's product portfolio features advanced ultrasonic platforms such as aspirators for soft and hard tissue removal, instruments for laparoscopic procedures, and devices for wound cleansing and debridement. Additionally, its offerings include tools for precision bone cutting and sculpting, as well as liposuction instruments aimed at improving body aesthetics. Notable products include BoneScalpel, NeXus, Sequel, SonaStar, SonicOne, Theragenesis, TheraSkin, and Therion. Misonix serves a global market, with a presence in regions such as the United States and the United Kingdom, contributing to the overall value of the healthcare system.
Vaporox
Corporate Round in 2021
Vaporox, Inc. is a medical technology company that specializes in developing a therapeutic delivery system aimed at treating various skin wounds. The firm's flagship product, Vaporous Hyperoxia Therapy, utilizes low-frequency ultrasonic waves to create antimicrobial particles, which are continuously delivered to the wound site. This innovative approach is designed to treat a range of conditions, including diabetic foot ulcers, amputations, burns, frostbite, gangrene, pressure ulcers, and skin grafts. Founded in 2016 and headquartered in Denver, Colorado, Vaporox aims to provide effective and comfortable treatment options for patients while also helping to prevent amputations at a lower cost. The technology has received FDA clearance, underscoring its potential in the health care sector.
Bioness
Acquisition in 2021
Bioness Inc. designs, develops, and distributes innovative medical devices aimed at helping individuals with neurological impairments regain mobility and independence. Founded in 2004 and based in Valencia, California, the company specializes in non-invasive technologies for conditions such as stroke, multiple sclerosis, traumatic brain injury, and spinal cord injury. Its product lineup includes the L300 foot drop system and the L300 Plus, which utilizes programmed electrical stimulation to activate leg muscles. Additionally, Bioness offers the H200, a wireless hand rehabilitation system that assists with hand movements, and StimRouter, an implantable device designed to alleviate chronic pain originating from peripheral nerves. Through these solutions, Bioness aims to improve the quality of life for individuals affected by various neurological disorders.
CartiHeal
Corporate Round in 2020
CartiHeal is a medical device company based in Kfar Sava, Israel, specializing in cartilage and bone regeneration. Founded in 2009, the company has developed the Agili-C implant, a cell-free and off-the-shelf solution designed to address focal articular cartilage and osteochondral defects. This innovative implant promotes the regeneration of hyaline cartilage and the underlying subchondral bone without the need for cells or growth factors, making it a significant advancement in the treatment of cartilage injuries. Given the limited natural healing capacity of hyaline cartilage, CartiHeal's technology offers a promising option for patients suffering from cartilage damage, which can lead to severe pain and disability if untreated. The Agili-C implant can be inserted using arthroscopic or minimally invasive techniques, facilitating faster rehabilitation and enhanced recovery outcomes for patients.
CartiHeal
Corporate Round in 2018
CartiHeal is a medical device company based in Kfar Sava, Israel, specializing in cartilage and bone regeneration. Founded in 2009, the company has developed the Agili-C implant, a cell-free and off-the-shelf solution designed to address focal articular cartilage and osteochondral defects. This innovative implant promotes the regeneration of hyaline cartilage and the underlying subchondral bone without the need for cells or growth factors, making it a significant advancement in the treatment of cartilage injuries. Given the limited natural healing capacity of hyaline cartilage, CartiHeal's technology offers a promising option for patients suffering from cartilage damage, which can lead to severe pain and disability if untreated. The Agili-C implant can be inserted using arthroscopic or minimally invasive techniques, facilitating faster rehabilitation and enhanced recovery outcomes for patients.
BioStructures
Acquisition in 2015
BioStructures, LLC is a medical device company founded in 2009 and based in Newport Beach, California. The company specializes in developing bioresorbable bone graft products aimed at enhancing bone regeneration and remodeling for various spinal surgical applications. Its product portfolio includes a range of offerings such as bioactive bone graft putties, mineralized collagen scaffolds, bone graft composites, and demineralized bone matrices. Additionally, BioStructures manufactures devices like bone marrow aspiration needles and hydrolyzed surgical powders. As of late 2015, BioStructures operates as a subsidiary of Bioventus LLC, focusing on advancing innovations in the field of spinal surgery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.